Fichtner-Feigl Stefan
Klinik für Allgemein- und Viszeralchirurgie, Universitätsklinikum Freiburg, Freiburg, Germany.
Visc Med. 2020 Oct;36(5):381-387. doi: 10.1159/000510488. Epub 2020 Sep 16.
The surgical approach in rectal cancer treatment has evolved in the last decades and a standardized surgical technique for tumor resection - total mesorectal excision - has been established.
In a multidisciplinary effort with the use of total mesorectal excision in combination with adjuvant and neoadjuvant treatments to compliment surgery disease management can achieve excellent long-term local control and improved patient survival. Further improvements in imaging techniques and the ability to identify prognostic factors such as tumor regression, extramural venous invasion, and threatened margins have introduced the concept of decision-making based on preoperative staging information.
Therefore, in the modern era treatment algorithms are based on high-resolution imaging to plan neoadjuvant therapy and precision surgery followed by pathological and molecular analysis to stratify patients for the need of adjuvant chemotherapy. Despite excellent results with guideline structured treatment pathways, there is still a need to improve long-term results especially for individuals with locally advanced or metastatic tumors.
在过去几十年中,直肠癌治疗的手术方法不断演变,现已确立了一种标准化的肿瘤切除手术技术——全直肠系膜切除术。
通过多学科协作,采用全直肠系膜切除术并结合辅助和新辅助治疗以补充手术,疾病管理可实现出色的长期局部控制并提高患者生存率。成像技术的进一步改进以及识别预后因素(如肿瘤退缩、壁外静脉侵犯和切缘受威胁)的能力引入了基于术前分期信息进行决策的概念。
因此,在现代,治疗方案基于高分辨率成像来规划新辅助治疗和精准手术,随后进行病理和分子分析,以对患者进行分层,确定是否需要辅助化疗。尽管遵循指南的结构化治疗路径取得了出色成果,但仍有必要改善长期疗效,尤其是对于局部晚期或转移性肿瘤患者。